A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

APHANZ want action on rural product approval backlog
Primary Sector

APHANZ want action on rural product approval backlog

A Cabinet paper from the Government's review is due to be drawn up in February.

Riley Kennedy 19 Dec 2024
Alliance Group pauses farmer-shareholder capital raise
Primary Sector

Alliance Group pauses farmer-shareholder capital raise

An external capital raising remains an option. 

Rebecca Howard 18 Dec 2024
Global dairy prices slip into Christmas
Primary Sector

Global dairy prices slip into Christmas

There was 4.5% less volume compared to the last auction.

Riley Kennedy 18 Dec 2024